Close

News

WuXi Vaccines Appoints Mr. Jian Dong as Chief Executive Officer

WuXi Vaccines, a global leading company with world-class vaccine contract development and manufacturing organization (CDMO) capabilities, is pleased to announce the appointment of Mr. Jian Dong as Chief Executive Officer (CEO). WuXi Vaccines is a joint venture established between...

Bayer to acquire UK-based biotech KaNDy Therapeutics Ltd

Bayer, a global leader in women’s healthcare, and KaNDy Therapeutics Ltd, a UK clinical-stage biotech company, announced that Bayer will acquire KaNDy Therapeutics Ltd. to expand its drug development pipeline in women’s healthcare. KaNDy Therapeutics Ltd. recently completed the...

TFF Pharmaceuticals Announces $25.9 Million in Financing to Further Advance Its Thin Film Freezing Technology Platform

TFF Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, announced that it has entered into a definitive agreement with a syndicate of high...

CPhI South East Asia rescheduled for 2021

CPhI South East Asia – organised by Informa Markets – has been rescheduled to May 18-20, 2021 to give the ASEAN pharma community more time to recover and to mitigate any global disruptions caused by COVID-19. “The decision to reschedule...

Russia announces world’s first Covid-19 vaccine, Putin’s daughter gets vaccinated

Amid the race to develop a Covid-19 vaccine, Russian President Vladimir Putin launched a coronavirus vaccine, touted as the world's first such vaccine, too. The registration of the vaccine lays ground for mass inoculation even as the final stages...

Clinerion named a Finalist in the Fierce Innovation Awards – Life Sciences Edition 2020

Clinerion announced that it has been selected as a finalist in the Fierce Innovation Awards – Life Sciences Edition 2020, a peer reviewed awards program from the publisher of Fierce Biotech and Fierce Pharma, produced by Questex. The competition highlights...

Phesi Powers Data-Driven Clinical Trials Through Addition of New Country Selection Functionality to ClinSite

Phesi, a data-driven provider of clinical development analytics products and solutions, announced a new country selection functionality has been added to ClinSite, its platform to provide investigator site intelligence to clients, enabling investigator site selection and management. The new...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read